Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Other Accumulated Expenses (2020 - 2024)

Historic Other Accumulated Expenses for Neuroone Medical Technologies (NMTC) over the last 5 years, with Q4 2024 value amounting to $258244.0.

  • Neuroone Medical Technologies' Other Accumulated Expenses rose 248244.0% to $258244.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $258244.0, marking a year-over-year increase of 248244.0%. This contributed to the annual value of $59950.0 for FY2024, which is N/A changed from last year.
  • Latest data reveals that Neuroone Medical Technologies reported Other Accumulated Expenses of $258244.0 as of Q4 2024, which was up 248244.0% from $59950.0 recorded in Q3 2024.
  • In the past 5 years, Neuroone Medical Technologies' Other Accumulated Expenses ranged from a high of $258244.0 in Q4 2024 and a low of $10000.0 during Q4 2023
  • Over the past 5 years, Neuroone Medical Technologies' median Other Accumulated Expenses value was $59950.0 (recorded in 2024), while the average stood at $92432.7.
  • Per our database at Business Quant, Neuroone Medical Technologies' Other Accumulated Expenses crashed by 8360.37% in 2022 and then surged by 248244.0% in 2024.
  • Neuroone Medical Technologies' Other Accumulated Expenses (Quarter) stood at $218125.0 in 2020, then crashed by 61.88% to $83152.0 in 2021, then plummeted by 73.54% to $22001.0 in 2022, then crashed by 54.55% to $10000.0 in 2023, then skyrocketed by 2482.44% to $258244.0 in 2024.
  • Its Other Accumulated Expenses was $258244.0 in Q4 2024, compared to $59950.0 in Q3 2024 and $17007.0 in Q1 2024.